Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05709782 · ClinicalTrials.gov registry record · Phase 2
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
A Phase 2 study of Spinal Disease, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05709782 is a Phase 2 study of Spinal Disease that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05709782, a Phase 2 study of Spinal Disease, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy given to the area around your spine.
Conditions Studied
Interventions
- PROCEDURE Spine Radiosurgery
- DEVICE Magnetic Resonance imaging
- RADIATION MR-LINAC
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-09 |
| Est. Completion | 2026-01-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05709782
The ClinicalTrials.gov registry entry for NCT05709782 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spinal Disease appearing as the primary indexed condition, and to 3 interventions - of which Spine Radiosurgery is the first listed.
NCT05709782 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05709782 about?
NCT05709782 is a clinical study titled "Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC". To learn whether giving spinal stereotactic radiosurgery (SRSS) that uses a more advanced imaging scan method called Magnetic Resonance imaging with a Linear Accelerator (MR-LINAC) during treatment will lead to improved responses to treatment and better quality of life. SRSS is radiation therapy giv...
What is the current status of trial NCT05709782?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2023-05-09. Estimated completion is 2026-01-31.
What conditions does trial NCT05709782 study?
This clinical trial studies the following conditions: Spinal Disease.
What interventions are being tested in trial NCT05709782?
The interventions under investigation include: Spine Radiosurgery (PROCEDURE), Magnetic Resonance imaging (DEVICE), MR-LINAC (RADIATION).
Who is sponsoring clinical trial NCT05709782?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05709782 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.